Craft

Asher Bio

Total Funding

$55.2 M

Asher Bio Summary

Company Summary

Overview
Asher Bio (also known as Asher Biotherapeutics) is a biotechnology company developing cis-targeted immunotherapies for cancer and other diseases. It offers beneficial immunotherapies with precise selectivity, optimized efficacy, and minimized toxicity. The company aims to enable selective activation of specific immune cell types by precisely directing different immune mediators against a range of target immune cell types and creating immunotherapies in cancer, autoimmune and infectious diseases.
Type
Private
Status
Active
Founded
2019
HQ
South San Francisco, CA, US | view all locations
Website
https://asherbio.com/
Cybersecurity rating
Sectors

Key People

  • Craig Gibbs

    Craig Gibbs, Chief Executive Officer and Director

    • Ivana Djuretic

      Ivana Djuretic, Founder, Chief Scientific Officer and Director

      • Kyle Elrod

        Kyle Elrod, Chief Operating Officer

        • Andy Yeung

          Andy Yeung, Founder, Chief Technology Officer

          LocationsView all

          1 location detected

          • South San Francisco, CA HQ

            United States

            650 Gateway Blvd #100

          Footer menu